Jonathon Nevett et Karen Thiel rejoignent le conseil d'administration de la Prevent Cancer Foundation
FOU DIFFUSION IMMÉDIATE
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Alexandrie, Virginie – La Fondation Prévenir le Cancer® announces the election of Jonathon Nevett and Karen Thiel to the Foundation’s board of directors. Their terms will begin on January 1, 2024. The Prevent Cancer Foundation is proud to welcome these accomplished individuals into their new roles.
Jonathan Nevett is the president and CEO of Public Interest Registry (PIR). A veteran of the domain name industry, Mr. Nevett co-founded Donuts Inc. in 2010 and has helped to raise in excess of $150 million to form a registry of over 240 internet domain extensions. Prior to this work, Mr. Nevett served as senior vice president at Network Solutions, where he was responsible for policy, government affairs, registry relations and the corporate ethics office.
Mr. Nevett is also the co-founder of the Domain Name Association, an industry trade association, and participated in various leadership roles at the Internet Corporation for Assigned Names and Numbers (ICANN). He has served on numerous boards, including as chair of the board of NameJet and Central Registry Solutions, two joint ventures in the domain name industry, and as vice chair of the board of the Green Acres School. During the Obama Administration, Mr. Nevett was appointed to the Online Safety and Technology Working Group to help protect children on the internet.
Mr. Nevett is a cancer survivor and shared what he learned about early detection in a recent blog post for PIR.
Karen Thiel previously served as senior counsel at the Kaiser Foundation Health Plan, where she was responsible for providing legal advice to Kaiser’s senior leadership and Medicaid programs. While a partner in the Health Policy practice at Patton Boggs LLP and then as senior counsel in the Public Policy Department at Akin Gump, Ms. Thiel provided pro bono work for the Smashing Walnuts Foundation to secure multiple years of funding for the National Institutes of Health. Additionally, she provided support to the National Institutes of Health’s Biospecimen-Related Research Program on ethical, legal and policy practices for biospecimen-related research, presented at conferences—including the National Cancer Institute’s Biospecimen Best Practices Forum—and co-authored an article on these issues that was published in Cancer Epidemiology Biomarkers & Prevention.
Ms. Thiel also worked in the California State Senate, where she worked with then-State Senator John Garamendi to secure funding for a Tobacco-Related Disease Research Program that supplied funding for important research in cancer prevention and detection by researchers in California’s public and private university system.
Ms. Thiel is a breast cancer survivor.
“We’re thrilled to have Jon and Karen’s expertise as they join our dynamic board and staff to help us achieve better outcomes for all,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “In addition to their leadership qualifications from two diverse industries, their personal connections to our work enable them to bring a unique set of perspectives that will help us empower more people to stay ahead of cancer through prevention and early detection.”
###
À propos de la Fondation Prévenir le Cancer®
La Fondation Prévenir le Cancer® est les seuls États-Unis-basé organisation à but non lucratif uniquement dédié à cancer prévention et précoce détection. Par la recherche, l'éducation, sensibilisation et plaidoyer, nous avons aidé d’innombrables personnes à éviter un diagnostic de cancer ou à détecter leur cancer suffisamment tôt pour être traité avec succès. Nous sommes conduits par une vision d'un monde où le cancer est évitable, détectable et battable pour tous.
La Fondation se mobilise pour relever le défi de réduire les décès par cancer de 40% d'ici 2035. Pour y parvenir, nous sommes s'est engagé à investir $20 millions dans des technologies innovantes permettant de détecter le cancer à un stade précoce et de progresser multi-dépistage du cancer, $10 millions pour élargir l'accès au dépistage du cancer et à la vaccination médicalement communautés mal desservies et $10 millions pour informer le public sur les options de dépistage et de vaccination.
Pour plus d'informations, s'il vous plaît visitez www.preventcancer.org.